Leon v. Shmukler

992 F. Supp. 2d 179, 2014 WL 204728, 2014 U.S. Dist. LEXIS 6531
CourtDistrict Court, E.D. New York
DecidedJanuary 17, 2014
DocketNo. 13-CV-3185 (JFB)(GRB)
StatusPublished
Cited by81 cases

This text of 992 F. Supp. 2d 179 (Leon v. Shmukler) is published on Counsel Stack Legal Research, covering District Court, E.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Leon v. Shmukler, 992 F. Supp. 2d 179, 2014 WL 204728, 2014 U.S. Dist. LEXIS 6531 (E.D.N.Y. 2014).

Opinion

MEMORANDUM AND ORDER

JOSEPH F. BIANCO, District Judge.

Plaintiffs Barry Leon (“Leon”); ABL Venture Capital, LLC (“ABL”); and OS Research, LLC (“OS Research”) (collectively, “plaintiffs”) bring this action against defendants Igor Shmukler (“Shmukler”); Thinomenon, Inc. (“Thinomenon”); and Gennady Mednikov (“Mednikov”) (collectively, “defendants”), under New York State contract and tort law and federal copyright law, based on defendants’ alleged misappropriation and use of intellectual property, assets, and information owned by OS Research. Plaintiffs seek declaratory and injunctive relief, and damages.

[184]*184Thinomenon and Mednikov presently move to dismiss the complaint. They argue that an arbitration in 2011 between Leon, ABL, OS Research, and Shmukler bars this suit under principles of res judicata. Mednikov separately argues that the Court lacks personal jurisdiction over him and the complaint fails to state a claim because plaintiffs proffer no allegations justifying holding Mednikov vicariously liable for Thinomenon’s actions. For the following reasons, the motion is granted in part and denied in part. First, the Court denies the motion as to Thinomenon because res judicata does not apply. Second, the Court concludes that plaintiffs have failed, at this juncture, to make a prima facie showing of jurisdiction as to Mednikov. However, the Court also concludes that plaintiffs have made a sufficient threshold showing — based upon Mednikov’s alleged position as President of Thinomenon and the alleged nature of the wrongful acts attributable to Thinomenon while he was President — that there is a good faith, arguable basis for personal jurisdiction that could be developed with the benefit of limited jurisdictional discovery. Therefore, the Court, in its discretion, will allow limited jurisdictional discovery as to Mednikov’s role at Thinomenon prior to any decision the personal jurisdiction issue. Accordingly, Mednikov’s motion is denied without prejudice to renewal following the completion of the jurisdictional discovery.

I. Background

A. Factual Background

The following facts are taken from the complaint and the exhibits attached thereto.1 These are not findings of fact by the Court; rather, the Court assumes these facts to be true for purposes of deciding this motion and construes them in the light most favorable to the non-moving parties.

Leon, a resident of New York, is the principal and controlling shareholder of ABL, a New York corporation. (Complaint ¶¶ 2-8.) OS Research, a joint venture between ABL, Shmukler, and a non-party, Shiotel Lebovic (“Lebovic”), is a New York corporation. (Id. ¶¶ 4-5.) ABL possesses a 71.59 percent membership and equity interest in OS Research. (Id. ¶ 6.) Thinomenon is an Illinois corporation based in Illinois. (Id. ¶ 8.) Mednikov, an Illinois resident, is Thinomenon’s registered agent, president, and secretary. (Id. ¶¶ 9-10.)

1. OS Research and the Arbitration

Around October 2002, ABL, Shmukler, and Lebovic formed OS Research. (Id. ¶ 15.) ABL, Shmukler, and Lebovic were the sole members, and their business relationship was and remains governed by the “OS Research, LLC Operating Agreement” (the “Agreement”). (Id ¶ 17; Agreement, Complaint Ex. 1.) Shmukler was the officer responsible for day-to-day operations, including hiring, retaining and supervising a team of contract-employee software developers, website designers, and salespeople to create, market, and sell a suite of software products. (Complaint ¶¶ 18-19.)

For ten years, OS Research developed software products and a desktop virtualization suite known as Elusiva. (See id. ¶¶ 28-31.) In approximately May 2011, however, Shmukler abruptly ceased all op[185]*185erations necessary to the normal functioning of OS Research. (Id. ¶ 35.) At that time, he refused to acknowledge ABL’s ownership and refused to return to OS Research or to ABL any of the proprietary information and other intellectual property he possessed, such as the Elusiva software products, their underlying code, the necessary contacts for the software developers contracted by OS Research, or the contact information of Elusiva’s business partners and customers. (Id.) Shmukler also refused to pay any percentage of the profits of OS Research to ABL, and he fled to Russia. (Id. ¶¶ 36-37.)

In response and pursuant to a clause in the Agreement requiring “[a]ny controversy, claim or dispute arising out of or relating to this Agreement” to be arbitrated in New York, Leon, ABL, and Letovic brought a July 2011 arbitration against Shmukler in New York. (Id. ¶38.) The moving defendants were not parties to the arbitration, which addressed two issues: the proportions of ownership ABL, Lebovic, and Shmukler held in OS Research and its assets, and whether Shmukler was entitled to control of OS Research’s assets. (Id. ¶¶ 38, 40; Arbitration Award, Complaint Ex. 3.) The arbitrators stated that the claims arose out of Shmukler’s discontinuation of OS Research’s operations and refusal to recognize ABL’s ownership and control of the entity. (See Arbitration Award, at 1.) The arbitrators did not consider claims based on the establishment or operation of any successor entity, or any claims based on other breaches of the Agreement or exploitation of the assets. (See generally id.) They determined that ABL owned 71.59 percent of OS Research and that Shmukler had no right to control or transfer its assets. (Id. at 2; Complaint ¶ 40.) Plaintiffs have been unable to serve Shmukler with the award. (Complaint ¶ 40.)

2. Thinomenon and Mednikov

Plaintiffs allege that Shmukler began planning his exit from OS Research before May 2011, and he incorporated Thinomenon a month after shutting down OS Research and taking Elusiva products and other assets. (Id. ¶¶41, 48.) Documents on file with the Illinois Secretary of State identify Mednikov as Thinomenon’s agent, president, and secretary, but they do not mention Shmukler. (Id. ¶¶ 8-9; Corporation Report, Complaint Ex. 6.) Thinomenon operates using a website at Thinomenon.com. (Id. ¶ 46.) It began selling the Elusiva products in its own name in mid-2011, and it continues to do so. (Id. ¶¶ 47-59.) Plaintiffs allege that Thinomenon’s products are “mere relabelings or revisions of, and are entirely derived from, OS Research’s Elusiva products and website.” (Id. ¶ 55.) Plaintiffs further allege that they have not been compensated for the use of their property; have not received allocations, distributions, or loan repayments as required by the Agreement; and have not been informed of management decisions in accordance with the rights granted them under the Agreement. (Id. ¶¶ 59.)

The specific allegations (factual and legal) against Mednikov are as follows:

(1) Shmukler transferred the assets and intellectual property of OS Research to Mednikov and Thinomenon, “or, in the alternative, has used and is using Mednikov and Thinomenon as a front for his own activities.” (Id. ¶ 62.) Thinomenon has made use of these products and is selling them under a new name. (Id.)
(2) Thinomenon and Mednikov, as Shmukler’s “successors and assigns, have failed to make payments and distributions to ABL under the Operating Agreement” and thus have [186]

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
992 F. Supp. 2d 179, 2014 WL 204728, 2014 U.S. Dist. LEXIS 6531, Counsel Stack Legal Research, https://law.counselstack.com/opinion/leon-v-shmukler-nyed-2014.